Ban could reduce the number of melanoma cases and decrease lifetime health care costs, despite compliance costs<\/p>\n<\/h3>\n
<\/b><\/p>\n
<\/b><\/p>\n
MONDAY, April 12, 2021 (HealthDay News) — A tanning bed ban for U.S. minors would be cost-effective, according to a study published online April 12 in Cancer<\/em>.<\/p>\n Antoine Eskander, M.D., from the University of Toronto, and colleagues modeled the potential health benefits and costs of banning tanning bed use by adolescents (aged 14 to 17 years). <\/p>\n The researchers found that full adherence to the ban prevented 15,102 melanoma cases and 3,299 recurrences among 17.1 million minors, saving $342.9 million in treatments costs over the lifetime of 61.2 million youth and providing an increase of 0.0002 quality-adjusted life years. A ban remained the dominant strategy despite the intervention costs of the ban and the economic losses to the indoor-tanning industry, with a savings of $12 per minor and $205.4 million among 17.1 million minors. For varying inspection costs and ban compliance, the findings remained robust, but were sensitive to a lower excess risk for melanoma with early exposure to tanning beds.<\/p>\n “When balancing measures are accounted for in an extended societal perspective analysis, even with extensive sensitivity analyses on the costs of inspections, noncompliance with a ban, and the risk of developing melanoma in those who have used tanning beds, a ban can be considered highly cost-effective,” the authors write.<\/p>\n Abstract\/Full Text (subscription or payment may be required)<\/a><\/p>\n <\/i><\/p>\n